Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|81|5-6|372-380

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.5-6, 2012-01, pp. : 372-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 361-368

Karger

Access to resources Recommend Favorite

Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?

By  

HEPATOLOGY, Vol. 62, Iss. 6, 2015-12 ,pp. : 1767-1778

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment

By  

Current Signal Transduction Therapy, Vol. 9, Iss. 1, 2014-04 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor 1 as a Target for the Therapy of Renal Cell Carcinoma

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 321-331

Karger

Access to resources Recommend Favorite

Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 930-941

John Wiley & Sons Inc

Access to resources Recommend Favorite